Chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits claiming its weedkiller Roundup causes cancer, following costly settlements and trials.
Legislation introduced in Iowa, Missouri, and Idaho this year, with wording supplied by Bayer, would protect pesticide companies from claims related to cancer if their labels complied with EPA regulations.
However, legal experts warn that the legislation could have broader consequences, potentially extending to any product liability claim or providing immunity from lawsuits of any kind.
Bayer described the legislation as a strategy to address the legal challenges it faces with thousands of claims asserting Roundup causes cancer, despite the EPA concluding it is not likely to be carcinogenic to humans.
The legislation has been introduced in key states for Bayer’s Roundup operations and is at different stages in each state.
Farmers heavily rely on Roundup, which was introduced 50 years ago as an efficient way to control weeds and reduce soil erosion, with many concerned about the potential impact of costly lawsuits on the availability of the product.
While the legislation has faced opposition and concerns about limiting legal actions, Bayer continues to advocate for it, emphasizing the importance of adhering to EPA labeling regulations.
Despite criticisms and concerns raised by critics and legal experts, Bayer representatives maintain that the legislation would not cut off other legal actions and would not impact existing lawsuits.
In Idaho, the bill was narrowly defeated, highlighting the ongoing debate and controversy surrounding the use of glyphosate in products like Roundup.
Overall, the legislation and the debate surrounding it reflect the complex and contentious issues surrounding product liability, consumer safety, and corporate interests.
